What is the current Vitrolife market capitalization?
The current market capitalization of Vitrolife is 23.92 B SEK.
Vitrolife Market capitalization 2024
Vitrolife Market capitalization
23.92 B SEK
Ticker
VITR.ST
ISIN
SE0011205202
WKN
A2JLT3
In 2024, Vitrolife's market cap stood at 23.92 B SEK, a -14.47% increase from the 27.97 B SEK market cap in the previous year.
The Vitrolife Market capitalization history
| YEAR | REVENUE (undefined SEK) | GROSS MARGIN (%) | NET INCOME (undefined SEK) |
|---|---|---|---|
| 2026e | 4.39 | 45,06 | 795.19 |
| 2025e | 4.04 | 48,95 | 676.98 |
| 2024e | 3.72 | 53,20 | 556.83 |
| 2023 | 3.51 | 56,32 | -3,851 |
| 2022 | 3.23 | 55,04 | 394 |
| 2021 | 1.68 | 62,24 | 340.97 |
| 2020 | 1.25 | 61,63 | 286.85 |
| 2019 | 1.48 | 63,42 | 382.79 |
| 2018 | 1.15 | 66,11 | 309.7 |
| 2017 | 1.05 | 65,16 | 263.64 |
| 2016 | 0.86 | 65,56 | 190.37 |
| 2015 | 0.72 | 67,16 | 182.85 |
| 2014 | 0.51 | 68,38 | 109.1 |
| 2013 | 0.45 | 66,40 | 56.3 |
| 2012 | 0.36 | 65,83 | 333.8 |
| 2011 | 0.36 | 66,92 | 30.4 |
| 2010 | 0.3 | 69,29 | 28.9 |
| 2009 | 0.27 | 70,25 | 34.1 |
| 2008 | 0.23 | 69,39 | 30 |
| 2007 | 0.19 | 68,61 | 36.1 |
| 2006 | 0.17 | 68,07 | 15.2 |
| 2005 | 0.12 | 69,03 | 14.9 |
| 2004 | 0.1 | 71,61 | 11.9 |
Vitrolife Aktienanalyse
What does Vitrolife do?
Vitrolife AB is a Swedish biotech company specializing in the development and marketing of products for in vitro fertilization (IVF) and regenerative medicine. It was founded in 1994 and has over 390 employees worldwide. The company's main business is IVF, offering a wide range of essential products for IVF treatment such as culture media, devices for semen analysis and preparation, embryo transfer techniques, and products for biopsy examinations and cryopreservation. Vitrolife has a presence in 110 countries and has expanded its market to China where there is a high demand for fertility treatments. The company also offers medical equipment for regenerative treatments. Vitrolife is a leading player in the IVF industry known for its high product quality and innovation. It collaborates with universities and research institutions globally to improve IVF technology and success rates. The company places importance on sustainability and environmental protection, using 100% animal-free ingredients in their culture media and practicing recycling and waste reduction in their production facilities. In summary, Vitrolife offers a wide range of products for IVF and regenerative medicine, with a focus on supporting IVF treatments. The company is a leader in its industry and actively participates in research. It is committed to sustainability and environmental responsibility. Vitrolife ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Vitrolife's Market Capitalization
Vitrolife's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Vitrolife's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Vitrolife's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Vitrolife’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Vitrolife Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Vitrolife.
How has the market capitalization of Vitrolife developed in recent years?
The market capitalization of Vitrolife has increased/decreased by -14.47% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Vitrolife?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Vitrolife?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Vitrolife have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Vitrolife pay?
Over the past 12 months, Vitrolife paid a dividend of 0.85 SEK . This corresponds to a dividend yield of about 0.48 %. For the coming 12 months, Vitrolife is expected to pay a dividend of 0.86 SEK.
What is the dividend yield of Vitrolife?
The current dividend yield of Vitrolife is 0.48 %.
When does Vitrolife pay dividends?
Vitrolife pays a quarterly dividend. This is distributed in the months of May, May, May, June.
How secure is the dividend of Vitrolife?
Vitrolife paid dividends every year for the past 6 years.
What is the dividend of Vitrolife?
For the upcoming 12 months, dividends amounting to 0.86 SEK are expected. This corresponds to a dividend yield of 0.49 %.
In which sector is Vitrolife located?
Vitrolife is assigned to the 'Health' sector.
Wann musste ich die Aktien von Vitrolife kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Vitrolife from 5/14/2024 amounting to 1 SEK, you needed to have the stock in your portfolio before the ex-date on 5/7/2024.
When did Vitrolife pay the last dividend?
The last dividend was paid out on 5/14/2024.
What was the dividend of Vitrolife in the year 2023?
In the year 2023, Vitrolife distributed 0.8 SEK as dividends.
In which currency does Vitrolife pay out the dividend?
The dividends of Vitrolife are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Vitrolife
Our stock analysis for Vitrolife Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vitrolife Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
